Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance

<p>Original picture</p>

Сохранить в:

Библиографические подробности
Главный автор:	Xiaodong Shu (16721586) (author)
Другие авторы:	Jianjie Li (16721589) (author), Un In Chan (16721592) (author), Sek Man Su (16721595) (author), Changxiang Shi (16721598) (author), Xin Zhang (16721601) (author), Tingting An (16721604) (author), Jun Xu (16721607) (author), Lihua Mo (16721610) (author), Jianlin Liu (16721613) (author), Yuqing Wang (16721616) (author), Xiaoling Li (16721619) (author), Min Deng (16721622) (author), Josh Haipeng Lei (16721625) (author), Chunfei Wang (16721628) (author), Hao Tian (16721631) (author), Sun Heng (16721634) (author), Joong Sup Shim (16721637) (author), Xuanjun Zhang (16721640) (author), Yunlu Dai (16721643) (author), Zhicheng Yao (16721646) (author), Xiaying Kuang (16721649) (author), Ying Lin (15293140) (author), Chu-Xia Deng (16721652) (author), Xiaoling Xu (16721655) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Biology Tumor Biology Immuno-oncology Breast Cancer Immunology Immunotherapy Checkpoint blockade Oncogenes & Tumor Suppressors Progression, Invasion & Metastasis Tumor Microenvironment
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
по: Xiaodong Shu (16721586)
Опубликовано: (2025)

Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
по: Christine Pich-Bavastro (16509238)
Опубликовано: (2025)

Supplementary Table S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
по: Christine Pich-Bavastro (16509238)
Опубликовано: (2025)

Supplementary Table S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
по: Christine Pich-Bavastro (16509238)
Опубликовано: (2025)

Supplementary Table S4 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
по: Christine Pich-Bavastro (16509238)
Опубликовано: (2025)

Supplementary Table S5 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
по: Christine Pich-Bavastro (16509238)
Опубликовано: (2025)

Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
по: Christine Pich-Bavastro (16509238)
Опубликовано: (2025)

Supplementary Table S7 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
по: Christine Pich-Bavastro (16509238)
Опубликовано: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
по: Kankan Cao (16437263)
Опубликовано: (2025)

Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
по: Sung-Eun Lee (14855067)
Опубликовано: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
по: Aleksandar Obradovic (7549517)
Опубликовано: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
по: Aleksandar Obradovic (7549517)
Опубликовано: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
по: Ruiyun Zhang (17142498)
Опубликовано: (2025)

Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
по: Clare Vesely (505402)
Опубликовано: (2025)

Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
по: Clare Vesely (505402)
Опубликовано: (2025)

Figure 3 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
по: Clare Vesely (505402)
Опубликовано: (2025)

Figure 4 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
по: Clare Vesely (505402)
Опубликовано: (2025)

Figure 5 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
по: Clare Vesely (505402)
Опубликовано: (2025)

Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
по: Clare Vesely (505402)
Опубликовано: (2025)

Supplementary Figures from NKG7 Is Required for Optimal Antitumor T-cell Immunity
по: Xian-Yang Li (15022958)
Опубликовано: (2025)

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
по: Arianna Draghi (15126339)
Опубликовано: (2025)

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
по: Arianna Draghi (15126339)
Опубликовано: (2025)

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
по: Arianna Draghi (15126339)
Опубликовано: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
по: Renumathy Dhanasekaran (14962092)
Опубликовано: (2025)

Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
по: Sonia A. Patel (15055688)
Опубликовано: (2025)

Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
по: Sonia A. Patel (15055688)
Опубликовано: (2025)

Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
по: Sonia A. Patel (15055688)
Опубликовано: (2025)

Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
по: Sonia A. Patel (15055688)
Опубликовано: (2025)

Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
по: Sonia A. Patel (15055688)
Опубликовано: (2025)

Supplementary video 1 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
по: Alvaro Teijeira (14962650)
Опубликовано: (2025)

Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
по: Alvaro Teijeira (14962650)
Опубликовано: (2025)

Supplementary video 3 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
по: Alvaro Teijeira (14962650)
Опубликовано: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
по: Hansol Lee (15054787)
Опубликовано: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
по: Hansol Lee (15054787)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_1bg0t2bhh1nje8piu0g4juc5gh